105 related articles for article (PubMed ID: 10577610)
1. New endocrine tumor markers of gynecologic malignancies. A review.
Kauppila A; Santala M
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):833-7. PubMed ID: 10577610
[No Abstract] [Full Text] [Related]
2. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
Okamoto T
Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
[No Abstract] [Full Text] [Related]
3. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
Okamoto T
Nihon Rinsho; 2010 Jul; 68 Suppl 7():803-6. PubMed ID: 20963909
[No Abstract] [Full Text] [Related]
4. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
Okamoto T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
[No Abstract] [Full Text] [Related]
5. The quagmire of hCG and hCG testing in gynecologic oncology.
Muller CY; Cole LA
Gynecol Oncol; 2009 Mar; 112(3):663-72. PubMed ID: 19007977
[TBL] [Abstract][Full Text] [Related]
6. The beta-core fragment of human chorionic gonadotropin: biochemical background and clinical application.
Schutter EM; Mulder C; van Kamp GJ; Kenemans P
Anticancer Res; 1997; 17(2B):1255-72. PubMed ID: 9137483
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of urinary gonadotropin peptides (UGP) in gynecologic oncology.
Schwartz PE; Cracchiolo BM; Cole LA
Anticancer Res; 1996; 16(4B):2135-9. PubMed ID: 8694533
[TBL] [Abstract][Full Text] [Related]
9. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
Schwarz-Roeger U; Petzoldt B; Waldschmidt R; Walker RP; Bauknecht T; Kiechle M
Anticancer Res; 1997; 17(4B):3041-5. PubMed ID: 9329597
[TBL] [Abstract][Full Text] [Related]
10. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
Schutter EM; Mijatovic V; Kok A; Van Kamp GJ; Verstraeten R; Verheijen RH
Anticancer Res; 1999; 19(6C):5551-7. PubMed ID: 10697615
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and functional biomarkers of value in female genital tract lesions: a systematic review with statistical meta-analysis.
Heatley MK
Int J Gynecol Pathol; 2007 Apr; 26(2):177-9. PubMed ID: 17413986
[No Abstract] [Full Text] [Related]
12. Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free beta-subunit: tumor markers and tumor promoters.
Cole LA; Butler SA
J Reprod Med; 2008 Jul; 53(7):499-512. PubMed ID: 18720925
[TBL] [Abstract][Full Text] [Related]
13. [Problems for tumor markers in gynecological malignancies].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):2-4. PubMed ID: 18366922
[No Abstract] [Full Text] [Related]
14. Assessing tumors in living animals through measurement of urinary beta-human chorionic gonadotropin.
Shih IM; Torrance C; Sokoll LJ; Chan DW; Kinzler KW; Vogelstein B
Nat Med; 2000 Jun; 6(6):711-4. PubMed ID: 10835692
[No Abstract] [Full Text] [Related]
15. [Progress in the study of the uses of proteomics in gynecologic oncology].
Yang YS; Chen JL; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):425-7. PubMed ID: 15312333
[No Abstract] [Full Text] [Related]
16. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
17. Screening, diagnosis, and monitoring of gynecologic malignancies.
Montz FJ; Berek JS
Curr Opin Oncol; 1989 Oct; 1(1):75-81. PubMed ID: 2489952
[No Abstract] [Full Text] [Related]
18. Human chorionic gonadotropin alpha subunit as a specific marker for malignancy in the Zollinger-Ellison syndrome.
Stabile BE; Braunstein GD; Hershman JM; Passaro EP
Surg Forum; 1978; 29():488-90. PubMed ID: 95723
[No Abstract] [Full Text] [Related]
19. Inhibins as biomarkers for reproductive cancers.
Robertson DM; McNeilage J
Semin Reprod Med; 2004 Aug; 22(3):219-25. PubMed ID: 15319824
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers and their use in gynecologic oncology].
Durdević S; Segedi D
Med Pregl; 1989; 42(11-12):457-60. PubMed ID: 2642208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
